ClearPoint Neuro Revenue 2010-2024 | CLPT
ClearPoint Neuro revenue from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| ClearPoint Neuro Annual Revenue (Millions of US $) |
|
|---|---|
| 2023 | $24 |
| 2022 | $21 |
| 2021 | $16 |
| 2020 | $13 |
| 2019 | $11 |
| 2018 | $7 |
| 2017 | $7 |
| 2016 | $6 |
| 2015 | $5 |
| 2014 | $4 |
| 2013 | $4 |
| 2012 | $5 |
| 2011 | $4 |
| 2010 | $3 |
| 2009 | $3 |
| ClearPoint Neuro Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2024-09-30 | $8 |
| 2024-06-30 | $8 |
| 2024-03-31 | $8 |
| 2023-12-31 | $7 |
| 2023-09-30 | $6 |
| 2023-06-30 | $6 |
| 2023-03-31 | $5 |
| 2022-12-31 | $5 |
| 2022-09-30 | $5 |
| 2022-06-30 | $5 |
| 2022-03-31 | $5 |
| 2021-12-31 | $4 |
| 2021-09-30 | $5 |
| 2021-06-30 | $3 |
| 2021-03-31 | $4 |
| 2020-12-31 | $4 |
| 2020-09-30 | $4 |
| 2020-06-30 | $2 |
| 2020-03-31 | $3 |
| 2019-12-31 | $3 |
| 2019-09-30 | $3 |
| 2019-06-30 | $3 |
| 2019-03-31 | $2 |
| 2018-12-31 | $2 |
| 2018-09-30 | $2 |
| 2018-06-30 | $2 |
| 2018-03-31 | $2 |
| 2017-12-31 | $2 |
| 2017-09-30 | $2 |
| 2017-06-30 | $2 |
| 2017-03-31 | $2 |
| 2016-12-31 | $2 |
| 2016-09-30 | $2 |
| 2016-06-30 | $1 |
| 2016-03-31 | $1 |
| 2015-12-31 | $2 |
| 2015-09-30 | $1 |
| 2015-06-30 | $1 |
| 2015-03-31 | $1 |
| 2014-12-31 | $1 |
| 2014-09-30 | $1 |
| 2014-06-30 | $1 |
| 2014-03-31 | $1 |
| 2013-12-31 | $1 |
| 2013-09-30 | $1 |
| 2013-06-30 | $1 |
| 2013-03-31 | $1 |
| 2012-12-31 | $2 |
| 2012-09-30 | $1 |
| 2012-06-30 | $1 |
| 2012-03-31 | $1 |
| 2011-12-31 | $1 |
| 2011-09-30 | $1 |
| 2011-06-30 | $1 |
| 2011-03-31 | $1 |
| 2010-12-31 | |
| 2009-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.338B | $0.024B |
| ClearPoint Neuro Inc. provides neurosurgery platform which includes hardware, software, clinical case and market development services for gene therapy cases principally in the United States and Europe. ClearPoint Neuro Inc., formerly known as MRI Interventions Inc., is based in Irvine, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $202.706B | 24.73 |
| Intuitive Surgical (ISRG) | United States | $193.352B | 101.09 |
| Alcon (ALC) | Switzerland | $43.519B | 29.12 |
| Edwards Lifesciences (EW) | United States | $41.599B | 26.42 |
| IQVIA Holdings (IQV) | United States | $36.625B | 20.18 |
| IDEXX Laboratories (IDXX) | United States | $35.273B | 41.54 |
| DexCom (DXCM) | United States | $30.978B | 46.65 |
| Waters (WAT) | United States | $22.985B | 33.99 |
| STERIS (STE) | Ireland | $21.603B | 24.87 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.257B | 0.00 |
| Hologic (HOLX) | United States | $17.928B | 19.36 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.368B | 13.72 |
| Sysmex ADR (SSMXY) | Japan | $13.192B | 41.37 |
| Globus Medical (GMED) | United States | $11.424B | 28.93 |
| Penumbra (PEN) | United States | $9.397B | 92.04 |
| Masimo (MASI) | United States | $9.192B | 44.48 |
| Teleflex (TFX) | United States | $9.024B | 14.39 |
| Glaukos (GKOS) | United States | $7.669B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $5.015B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.655B | 26.38 |
| Veracyte (VCYT) | United States | $3.419B | 102.61 |
| Inari Medical (NARI) | United States | $3.051B | 0.00 |
| TransMedics (TMDX) | United States | $2.857B | 90.57 |
| LivaNova (LIVN) | United Kingdom | $2.839B | 16.39 |
| Nihon Kohden (NHNKY) | Japan | $2.480B | 18.84 |
| Elekta AB (EKTAY) | Sweden | $2.209B | 19.86 |
| Tandem Diabetes Care (TNDM) | United States | $2.135B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.897B | 9.91 |
| RxSight (RXST) | United States | $1.848B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.448B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.284B | 0.00 |
| Artivion (AORT) | United States | $1.242B | 82.28 |
| OPKO Health (OPK) | United States | $1.044B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.901B | 15.31 |
| Paragon 28 (FNA) | United States | $0.864B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.738B | 0.00 |
| IRadimed (IRMD) | United States | $0.682B | 36.87 |
| Mesa Laboratories (MLAB) | United States | $0.660B | 15.55 |
| AxoGen (AXGN) | United States | $0.641B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.628B | 0.00 |
| SiBone (SIBN) | United States | $0.561B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.547B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.529B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.503B | 29.61 |
| Tactile Systems Technology (TCMD) | United States | $0.446B | 24.14 |
| Delcath Systems (DCTH) | United States | $0.404B | 0.00 |
| CVRx (CVRX) | United States | $0.377B | 0.00 |
| NeuroPace (NPCE) | United States | $0.337B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.290B | 0.00 |
| Inogen (INGN) | United States | $0.241B | 0.00 |
| Accuray (ARAY) | United States | $0.216B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.211B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.204B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.182B | 0.00 |
| Nevro (NVRO) | United States | $0.160B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.160B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.140B | 15.02 |
| Spectral Diagnostics (EDTXF) | Canada | $0.116B | 0.00 |
| 908 Devices (MASS) | United States | $0.100B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.092B | 0.00 |
| LENSAR (LNSR) | United States | $0.088B | 0.00 |
| InspireMD (NSPR) | Israel | $0.080B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.079B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.074B | 0.00 |
| Hyperfine (HYPR) | United States | $0.073B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.073B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.070B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.058B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.056B | 0.00 |
| Envoy Medical (COCH) | United States | $0.046B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.043B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.041B | 0.00 |
| Spectral AI (MDAI) | United States | $0.041B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.036B | 0.00 |
| Neuronetics (STIM) | United States | $0.034B | 0.00 |
| Precision Optics (POCI) | United States | $0.031B | 0.00 |
| DarioHealth (DRIO) | United States | $0.026B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.026B | 0.00 |
| NexGel (NXGL) | United States | $0.023B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.016B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.015B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.014B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.012B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |